Literature DB >> 23519538

Consensus on the regional lymph nodes irradiation in breast cancer.

E Bayo1, I Herruzo, M Arenas, M Algara.   

Abstract

Standard locoregional treatment of early-stage breast cancer currently consists of the conservative surgery and sentinel lymph node biopsy. In the event of positive sentinel node biopsy, an axillary level I-II lymphadenectomy should be carried out. However, recent publications have increasingly supported a tendency not to apply the surgical lymphadenectomy, but simultaneously, it has been developed a new role of regional radiotherapy, even if there is only 1-3 axillary lymph nodes involved. Given these new trends, radiation oncologists are facing the dilemma with regard to deciding about regional irradiation of breast cancer. For such purpose, The Spanish Group of Breast Cancer Radiation Oncology (GEORM as per its Spanish acronym) decided to reach a consensus to issue the respective guidelines for such types of cases. GEORM Managing Commission, gathering 13 members of different Spanish regional communities, issued a questionnaire including different clinical situations. These questions were set as key questions seeking responses, which were answered by 66 % out of the 75 members of the group. Following the response, the guidelines were drafted based on the replies to the mentioned questionnaire. All the respective issues were discussed by means of a virtual platform. In this article, we show the levels of consensus for different clinical situations, depending on the number of nodes involved and the type of surgical procedure performed on the axillary lymph nodes. The ongoing evolution of the oncological treatments obliges the radiation oncologists to take decisions without any existing clarifying evidence, and therefore, the consensus is necessary, which can assist in the decision-making process by the practitioners in such kinds of clinical situations.

Entities:  

Mesh:

Year:  2013        PMID: 23519538     DOI: 10.1007/s12094-013-1027-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  50 in total

Review 1.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

2.  Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.

Authors:  Jeremy Setton; Hiram Cody; Lee Tan; Monica Morrow; Clifford Hudis; Jeffrey Catalano; Beryl McCormick; Simon Powell; Alice Ho
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

3.  Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.

Authors:  Zhen Wang; Liu-Cheng Wu; Jun-Qiang Chen
Journal:  Breast Cancer Res Treat       Date:  2011-07-09       Impact factor: 4.872

4.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Authors:  Joseph Ragaz; Ivo A Olivotto; John J Spinelli; Norman Phillips; Stewart M Jackson; Kenneth S Wilson; Margaret A Knowling; Christopher M L Coppin; Lorna Weir; Karen Gelmon; Nhu Le; Ralph Durand; Andrew J Coldman; Mohamed Manji
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

5.  Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram.

Authors:  Amy C Degnim; Carol Reynolds; Gouri Pantvaidya; Shaheen Zakaria; Tanya Hoskin; Sunni Barnes; Margaret V Roberts; Peter C Lucas; Kevin Oh; Meryem Koker; Michael S Sabel; Lisa A Newman
Journal:  Am J Surg       Date:  2005-10       Impact factor: 2.565

6.  A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up.

Authors:  Gabriele Martelli; Patrizia Boracchi; Michaela De Palo; Silvana Pilotti; Saro Oriana; Roberto Zucali; Maria Grazia Daidone; Giuseppe De Palo
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

7.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

Authors:  Benjamin D Smith; Douglas W Arthur; Thomas A Buchholz; Bruce G Haffty; Carol A Hahn; Patricia H Hardenbergh; Thomas B Julian; Lawrence B Marks; Dorin A Todor; Frank A Vicini; Timothy J Whelan; Julia White; Jennifer Y Wo; Jay R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-15       Impact factor: 7.038

Review 8.  Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities.

Authors:  John Yarnold; Søren M Bentzen; Charlotte Coles; Joanne Haviland
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

9.  Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study.

Authors:  Paul D Gobardhan; Sjoerd G Elias; Eva V E Madsen; Bob van Wely; Frits van den Wildenberg; Evert B M Theunissen; Miranda F Ernst; Marike C Kokke; Carmen van der Pol; Inne H M Borel Rinkes; Jan H Wijsman; Vivian Bongers; Joost van Gorp; Thijs van Dalen
Journal:  Ann Surg Oncol       Date:  2010-12-14       Impact factor: 5.344

10.  Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases.

Authors:  C H M van Deurzen; R van Hillegersberg; M G G Hobbelink; C A Seldenrijk; R Koelemij; P J van Diest
Journal:  Cell Oncol       Date:  2007       Impact factor: 6.730

View more
  2 in total

1.  International Variation in Criteria for Internal Mammary Chain Radiotherapy.

Authors:  F K Duane; P McGale; S Teoh; C Mortimer; J Broggio; S C Darby; D Dodwell; B Lavery; S Oliveros; K A Vallis; C W Taylor
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-05-03       Impact factor: 4.126

2.  OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized open label trial.

Authors:  Manuel Algara López; Elvira Rodríguez García; Inmaculada Beato Tortajada; Francisco José Martínez Arcelus; Juan Salinas Ramos; José Reyes Rodríguez Garrido; Xavier Sanz Latiesas; Ana Soler Rodríguez; Germán Juan Rijo; Amanda Flaquer García
Journal:  Radiat Oncol       Date:  2020-10-02       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.